
|Articles|June 1, 2005
- Volume 0 0
Liver May Hold Key to Good Cholesterol
Advertisement
A recent study that gene-targeted mice found that good cholesterolmay be generated in the liver. In an effort to find clues tothe rare Tangier disease, in which affected people are unable toproduce high-density lipoprotein (HDL), researchers found thatthe liver is the source of 80% of HDL.
Scientists had previously believed that HDL was formedthroughout the body, particularly in the blood vessel walls. Thisnew finding could lead the way for a variety of drugs to be developed.Besides Tangier disease, low HDL is associated with ahigher risk of heart attack.
Articles in this issue
over 21 years ago
Consensus Guidelines for Hormone Therapyover 21 years ago
OTC Therapies for Allergic Rhinitisover 21 years ago
A Pharmacist's Guide to OTC Therapy: Menstrual Pain Productsover 21 years ago
A Pharmacist's Guide to OTC Therapy: Calcium Supplementsover 21 years ago
RxPRODUCT NEWS: PROFILE: Boniva (ibandronate)over 21 years ago
PhRMA Revamps Web Siteover 21 years ago
Ovulation-Prediction Testing Kits: A Woman's Choiceover 21 years ago
Examining Antithrombotic Therapyover 21 years ago
Web Site Expands ServicesAdvertisement
Related to this article

A current pharmacy resident provides insights on how pharmacy students can manage the transition from student to resident.

A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.

Phase 2 DeLLphi-309 data show comparable activity in previously treated SCLC with less frequent dosing.

The most enduring resources a preceptor can give students are the confidence and tools to ask deeper questions.

Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.

Two recent graduates share strategies for standing out in the competitive fellowship application process.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Beyond Prescription Volume: Measuring the Pharmacist’s Value
2
Medicare GLP-1 Bridge Runs Outside Part D and Pharmacy Teams Need a Different Workflow
3
FDA Approves Talazoparib With Enzalutamide for HRR-Mutated Metastatic Prostate Cancer
4
GLP-1 RAs, Finerenone, and CKD: Key Data From Kidney Week 2026
5


